Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL)
| 40.43 Delayed Data As of 3:59pm ET |  +3.02 / +8.07%Today’s Change | 23.28 Today|||52-Week Range 61.29 | -22.16% Year-to-Date |
Latest ZNTL News | Press Releases
| Zentalis Pharmaceuticals Inc (ZNTL) President & CEO Anthony Y Sun Sold $2.8 million of Shares Apr 07 / GuruFocus News - Paid Partner Content | Zentalis Pharmaceuticals Inc (ZNTL) COO Kevin D. Bunker Sold $1.1 million of Shares Apr 06 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 37.41 |
| Today’s open | 42.74 |
| Day’s range | 39.00 - 42.74 |
| Volume | 37,782 |
| Average volume (3 months) | 354,969 |
| Market cap | $1.5B |
Data as of 3:59pm ET, 04/12/2021
Growth & Valuation
| Earnings growth (last year) | -116.74% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Next reporting date | May 14, 2021 |
| EPS forecast (this quarter) | -$1.03 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$45.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
